Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASSERMalaria: HS-RDT Screening and DP Treatment in Pregnant Women
NCT04147546Phase 3Completed
- Sponsor
- Institut de Recherche en Sciences de la Santé
- Start
- Aug 2020
- Primary completion
- Aug 2021
- Modality
- Bivalent/Multivalent Binders, Nucleic Acid-Directed Small Molecules, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of dihydroartemisinin + piperaquine in Plasmodium falciparum malaria, sponsored by Institut de Recherche en Sciences de la Santé. Started Aug 2020; status: completed.
02
Drugs
dihydroartemisinin + piperaquine
03
Conditions
Plasmodium falciparum malaria
Beyond the preview
Go deeper on NCT04147546.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04147546.